Professor Dieter Wolke has appeared in the top 0.1% of the world’s researchers across 21 research fields for the 5th year in Succession.

Each year, Clarivate™ identifies the world’s most influential researchers ─ the select few who have been most frequently cited by their peers over the last decade. In 2022, fewer than 7,000, or about 0.1%, of the world’s researchers, in 21 research fields and across multiple fields, have earned this exclusive distinction.

Professor Dieter Wolke is among this elite group recognized for his exceptional research influence, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year in the Web of Science™.

6,938 Highly Cited Researchers in 2022

Health-Related Quality-of-Life Outcomes of Very Preterm or Very Low Birth Weight Adults: Evidence From an Individual Participant Data Meta-Analysis

Background and Objective

Assessment of health-related quality of life for individuals born very preterm and/or low birthweight (VP/VLBW) offers valuable complementary information alongside biomedical assessments. However, the impact of VP/VLBW status on health-related quality of life in adulthood is inconclusive. The objective of this study was to examine associations between VP/VLBW status and preference-based health-related quality-of-life outcomes in early adulthood.

University of Helsinki awards Prof Dieter Wolke its highest honour

Professor Dieter Wolke from the University of Warwick’s Department of Psychology will be bestowed with the rare accolade of an Honorary Doctorate from the University of Helsinki.

Professor Dieter Wolke

At what will only be the fifteenth ceremony of a two-century-old tradition, Professor Wolke will receive the institution’s highest award — the doctor honoris causa — from Helsinki’s Faculty of Medicine, in recognition of his distinguished and impactful career in Psychology.

Standardized Outcome Measures for Preterm and Hospitalized Neonates: An ICHOM Standard Set

Approximately, one in ten infants is born preterm or requires hospitalization at birth. These complications at birth have long-term consequences that can extend into childhood and adulthood. Timely detection of developmental delay through surveillance could enable tailored support for these babies and their families. However, the possibilities for follow-up are limited, especially in middle- and low-income countries, and the tools to do so are either not available or too expensive. A standardized and core set of outcomes for neonates, with feasible tools for evaluation and follow-up, could result in improving quality, enhance shared decision-making, and enable global benchmarking.